We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-18.58%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$736M
AUM Growth
-$206M
Cap. Flow
-$15M
Cap. Flow %
-2.04%
Top 10 Hldgs %
41.67%
Holding
172
New
4
Increased
40
Reduced
22
Closed
68

Top Buys

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$19.6M
2
AERI
Aerie Pharmaceuticals
AERI
+$16.7M
3
GILD icon
Gilead Sciences
GILD
+$11.1M
4
IMMU
Immunomedics Inc
IMMU
+$10.5M
5
CELG
Celgene Corp
CELG
+$8.56M

Top Sells

Rank Stock Value
1
KTWO
K2M Group Holdings, Inc
KTWO
+$24.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$16.9M
3
COLL icon
Collegium Pharmaceutical
COLL
+$14.2M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$13M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 81.78%
2 Technology 1.41%
3 Industrials 1.2%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRVS icon
101
Corvus Pharmaceuticals
CRVS
$1.1B
$46K 0.01%
12,594
– –
TTPH
102
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$45K 0.01%
1,991
– –
PLX icon
103
Protalix BioTherapeutics
PLX
$183M
$31K ﹤0.01%
9,967
– –
CLSD
104
DELISTED
Clearside Biomedical
CLSD
$28K ﹤0.01%
1,731
– –
AGIO icon
105
Agios Pharmaceuticals
AGIO
$2.08B
– –
-56,207
Closed -$4.33M
ALKS icon
106
Alkermes
ALKS
$8.11B
– –
-20,585
Closed -$874K
AMRX icon
107
Amneal Pharmaceuticals
AMRX
$6.1B
– –
-9,040
Closed -$201K
AVDL
108
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-15,218
Closed -$67K
AZN icon
109
AstraZeneca
AZN
$269B
– –
-3,550
Closed -$281K
BAX icon
110
Baxter International
BAX
$12.8B
– –
-3,298
Closed -$254K
BLUE
111
DELISTED
bluebird bio
BLUE
– –
-228
Closed -$432K
CAH icon
112
Cardinal Health
CAH
$53.7B
– –
-6,171
Closed -$333K
DHR icon
113
Danaher
DHR
$138B
– –
-4,011
Closed -$386K
ESPR
114
DELISTED
Esperion Therapeutics
ESPR
– –
-96,100
Closed -$4.26M
GSK icon
115
GSK
GSK
$107B
– –
-5,840
Closed -$293K
HRTX icon
116
Heron Therapeutics
HRTX
$93.4M
– –
-15,243
Closed -$482K
ICLR icon
117
Icon
ICLR
$13.7B
– –
-1,780
Closed -$274K
INCY icon
118
Incyte
INCY
$25.4B
– –
-11,113
Closed -$768K
IOVA icon
119
Iovance Biotherapeutics
IOVA
$2.04B
– –
-12,957
Closed -$146K
IRWD icon
120
Ironwood Pharmaceuticals
IRWD
$586M
– –
-18,388
Closed -$284K
ISRG icon
121
Intuitive Surgical
ISRG
$127B
– –
-1,878
Closed -$359K
MASI
122
DELISTED
Masimo
MASI
– –
-35,102
Closed -$4.37M
MCK icon
123
McKesson
MCK
$104B
– –
-3,842
Closed -$510K
NBIX icon
124
Neurocrine Biosciences
NBIX
$18.2B
– –
-6,803
Closed -$836K
NKTR icon
125
Nektar Therapeutics
NKTR
$2.39B
– –
-5,484
Closed -$5.01M
3 4
5
6 7

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Sectoral Asset Management held 172 positions worth $736M, down 22% from $942M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sectoral Asset Management's Q4 2018 filing shows 4 new, 40 increased, 22 reduced and 68 closed positions. Its largest new stake was Kineta, Inc. Common Stock: 11,298 shares worth $5.13M. The largest sale was K2M Group Holdings, Inc, an estimated $24.8M.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, down from 85% a quarter earlier, followed by Technology and Industrials.

  • Sectoral Asset Management's largest Q4 2018 buy was Kineta, Inc. Common Stock: 11,298 shares worth $5.13M.
  • Sectoral Asset Management added most to Teladoc Health in Q4 2018, an estimated $19.6M increase.
  • Sectoral Asset Management's biggest Q4 2018 reduction was Johnson & Johnson, cutting an estimated $16.9M.
  • Sectoral Asset Management fully exited K2M Group Holdings, Inc in Q4 2018, selling an estimated $24.8M.
  • Sectoral Asset Management's ten largest holdings make up 42% of its $736M portfolio in Q4 2018.
  • Sectoral Asset Management opened 4 new positions and closed 68 in Q4 2018.
  • Sectoral Asset Management's portfolio value fell 22% quarter-over-quarter to $736M.

Based on Sectoral Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.